Home Cart 0 Sign in  
X

[ CAS No. 22996-21-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 22996-21-0
Chemical Structure| 22996-21-0
Chemical Structure| 22996-21-0
Structure of 22996-21-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 22996-21-0 ]

Related Doc. of [ 22996-21-0 ]

Alternatived Products of [ 22996-21-0 ]

Product Details of [ 22996-21-0 ]

CAS No. :22996-21-0 MDL No. :MFCD00024254
Formula : C8H7NO4 Boiling Point : -
Linear Structure Formula :- InChI Key :KLTDQLIGNSBZPO-UHFFFAOYSA-N
M.W : 181.15 Pubchem ID :357691
Synonyms :

Calculated chemistry of [ 22996-21-0 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 3
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 47.14
TPSA : 72.12 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.38 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.09
Log Po/w (XLOGP3) : 1.45
Log Po/w (WLOGP) : 1.42
Log Po/w (MLOGP) : 0.03
Log Po/w (SILICOS-IT) : -0.17
Consensus Log Po/w : 0.76

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.02
Solubility : 1.73 mg/ml ; 0.00955 mol/l
Class : Soluble
Log S (Ali) : -2.57
Solubility : 0.487 mg/ml ; 0.00269 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.85
Solubility : 2.54 mg/ml ; 0.014 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 3.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.88

Safety of [ 22996-21-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 22996-21-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 22996-21-0 ]
  • Downstream synthetic route of [ 22996-21-0 ]

[ 22996-21-0 ] Synthesis Path-Upstream   1~19

  • 1
  • [ 22996-21-0 ]
  • [ 49609-15-6 ]
Reference: [1] Patent: WO2016/130968, 2016, A1,
  • 2
  • [ 22996-21-0 ]
  • [ 57559-52-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 18, p. 6254 - 6276
  • 3
  • [ 22996-21-0 ]
  • [ 33844-21-2 ]
  • [ 141080-74-2 ]
Reference: [1] Journal of Fluorine Chemistry, 2007, vol. 128, # 12, p. 1461 - 1468
  • 4
  • [ 22996-21-0 ]
  • [ 90151-04-5 ]
YieldReaction ConditionsOperation in experiment
61% With boron tribromide In dichloromethane at 0 - 20℃; for 4.5 h; To a stirred solution of 4-m robenzaldehyde (4.5 g, 24.84 mmol) in dichloromethane (100 mL) at 0 °C was added boron tribromide (8 mL, 84.5 mmol) dropwise. The mixture was stirred for thirty minutes at 0 °C and an additional four hours at room temperature. The reaction mixture was poured into ice water (200 mL) and stirred for two days. The mixture was extracted twice with ethyl acetate. The combined organic layers were washed with water, brine, dried (Na2SO4) and concentrated. The resulting residue was purified via MPLC eluting with a gradient of ethyl acetate/petroleum ether (1:15-1:5) to afford 4- hydroxy-2-nitrobenzaldehyde (2.55 g, 61percent) as an orange solid.
Reference: [1] Patent: WO2015/171610, 2015, A2, . Location in patent: Paragraph 000656
[2] Patent: WO2010/48582, 2010, A1, . Location in patent: Page/Page column 170-171
  • 5
  • [ 17484-36-5 ]
  • [ 22996-21-0 ]
YieldReaction ConditionsOperation in experiment
67%
Stage #1: With N-Bromosuccinimide; dibenzoyl peroxide In tetrachloromethane for 4.5 h; Heating / reflux
Stage #2: With silver (II) carbonate In water; acetone at 20℃;
Example 4Preparation of 3-(7-(l-Methylpiperidin-4-yloxy)quinazolin-2-ylarnino)benzenesulfonanτideStep 1. Preparation of 4-methoxy-2-nitrobenzaldehydeCompound 5 (20.43 g, 0.122 mol, 1.0 eq) was dissolved in 480 ml OfCCl4 under Ar. NBS (48.94 g, 0.275 mol, 2.2 eq) was added to the solution as a solid in one portion followed by addition of benzoyl peroxide (0.67 g, 2.76 mmol). The reaction mixture was stirred under reflux conditions for 4.5 hours. The 1H NMR of an aliquot showed ~ 90percent conversion of starting material to dibromo derivative.The reaction mixture was cooled to RT, and concentrated. CCI4 was chased twice with acetone. The residue was taken into acetone (IL) and Ag2COa (37.1 g, 0.135 mol, 1.1 eq) was added followed by addition of water (100 mL). The reaction mixture was left stirring at RT overnight. TLC ( EtOAc: Hexanes= 3:7) showed a new spot. The reaction mixture was filtered though <n="311"/>PP028218.0002celite, and the filter cake was washed with acetone and the filtrate was concentrated. 340 mL of H2O was added to the crude and the product was extracted with EtOAc (800 mL, 400 mL). The emulsion that formed was filtered through celite and the layers were separated. The organic layer was washed with hrine, dried over Na2SO4, and concentrated to give 8.27 g of crude material, which was purified by column chromatography (EtOAc/Hexanes) giving 14.7 g (67percent yield) of pure compound.
Reference: [1] Patent: WO2007/117607, 2007, A2, . Location in patent: Page/Page column 309-310
[2] Journal of the Chemical Society, 1949, p. Spl. 231
[3] Chemical and Pharmaceutical Bulletin, 1962, vol. 10, p. 856 - 865
[4] J. Gen. Chem. USSR (Engl. Transl.), 1960, vol. 30, p. 3091 - 3095[5] Zhurnal Obshchei Khimii, 1960, vol. 30, # 9, p. 3118
[6] Journal of Organic Chemistry, 2003, vol. 68, # 23, p. 9100 - 9104
[7] Journal of Organic Chemistry, 1984, vol. 49, # 7, p. 1238 - 1246
[8] Patent: US2813128, 1955, ,
[9] Collection of Czechoslovak Chemical Communications, 1960, vol. 25, p. 784 - 796
[10] Patent: WO2016/112088, 2016, A1,
[11] Patent: WO2008/101979, 2008, A1,
  • 6
  • [ 123-11-5 ]
  • [ 22996-21-0 ]
YieldReaction ConditionsOperation in experiment
89% at 0 - 20℃; for 0.5 h; Inert atmosphere General procedure: 10 mmol of the desired p-substituted benzaldehyde was dissolved in 5 mL of conc. sulfuric acid, and cooled to 0 °C, and then 1.2 equiv. of nitric acid was dissolved in 1 mL of conc. sulfuric acid, and then slowly added to the reaction mixture. The reaction was allowed to warmgradually to room temperature and stirred for 30 min at room temperature. It was then poured into 50 mL of ice-cold water. The produced precipitate was filtered and washed with cold water. The product was purified on reverse phase column chromatography with gradient increase of methanol in water containing 0.1percent of formic acid as eluent.
Reference: [1] European Journal of Medicinal Chemistry, 2014, vol. 77, p. 361 - 377
[2] Drug Development Research, 2016, p. 241 - 250
  • 7
  • [ 38469-83-9 ]
  • [ 22996-21-0 ]
Reference: [1] Organic Letters, 2001, vol. 3, # 13, p. 2053 - 2056
  • 8
  • [ 22996-23-2 ]
  • [ 22996-21-0 ]
Reference: [1] Journal of Natural Products, 2008, vol. 71, # 3, p. 313 - 320
[2] Journal of Medicinal Chemistry, 2006, vol. 49, # 21, p. 6412 - 6415
  • 9
  • [ 1335101-95-5 ]
  • [ 22996-21-0 ]
YieldReaction ConditionsOperation in experiment
5 g With sodium periodate In tetrahydrofuran; water at 35℃; for 16 h; To a mixture of (E)-l-(4-methoxy-2- nitrostyryl)pyrrolidine (7.4 g, 30 mmol) in THF (80 mL) was added a solution of NalC (16 g, 75 mmol) in H2O (240 mL). The reaction mixture was stirred at 35 °C for 16 hr then extracted with DCM (100 mL). The organic layer was separated, dried over anhydrous Na2SC>4, and concentrated under reduced pressure.[0229] The residue was purified by flash column chromatography to afford 4-methoxy-2- nitrobenzaldehyde (5 g, 92percent yield). LC-MS: m/z 182 (M+H)+.
Reference: [1] Patent: WO2016/112088, 2016, A1, . Location in patent: Paragraph 0228-0229
  • 10
  • [ 57559-52-1 ]
  • [ 22996-21-0 ]
Reference: [1] Journal of Organic Chemistry, 1984, vol. 49, # 7, p. 1238 - 1246
[2] Journal of Organic Chemistry, 2003, vol. 68, # 23, p. 9100 - 9104
[3] Patent: US2813128, 1955, ,
[4] Organic and Biomolecular Chemistry, 2008, vol. 6, # 18, p. 3284 - 3291
  • 11
  • [ 5344-78-5 ]
  • [ 22996-21-0 ]
Reference: [1] Journal of Fluorine Chemistry, 2007, vol. 128, # 12, p. 1461 - 1468
  • 12
  • [ 75-17-2 ]
  • [ 96-96-8 ]
  • [ 22996-21-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 9, p. 2397 - 2407
  • 13
  • [ 33844-21-2 ]
  • [ 22996-21-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 21, p. 6412 - 6415
[2] Journal of Medicinal Chemistry, 2011, vol. 54, # 22, p. 7834 - 7847
  • 14
  • [ 123-11-5 ]
  • [ 22996-21-0 ]
  • [ 31680-08-7 ]
Reference: [1] Journal of Organic Chemistry, 2011, vol. 76, # 19, p. 8088 - 8094
  • 15
  • [ 100193-41-7 ]
  • [ 22996-21-0 ]
Reference: [1] Collection of Czechoslovak Chemical Communications, 1960, vol. 25, p. 784 - 796
  • 16
  • [ 2042-14-0 ]
  • [ 22996-21-0 ]
Reference: [1] J. Gen. Chem. USSR (Engl. Transl.), 1960, vol. 30, p. 3091 - 3095[2] Zhurnal Obshchei Khimii, 1960, vol. 30, # 9, p. 3118
  • 17
  • [ 50-00-0 ]
  • [ 96-96-8 ]
  • [ 22996-21-0 ]
Reference: [1] Journal of Organic Chemistry USSR (English Translation), 1969, vol. 5, p. 938 - 941[2] Zhurnal Organicheskoi Khimii, 1969, vol. 5, # 5, p. 953 - 956
  • 18
  • [ 22996-21-0 ]
  • [ 99532-52-2 ]
Reference: [1] Organic and Biomolecular Chemistry, 2017, vol. 15, # 32, p. 6702 - 6705
  • 19
  • [ 22996-21-0 ]
  • [ 187731-65-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 22, p. 7834 - 7847
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 22996-21-0 ]

Aryls

Chemical Structure| 20357-24-8

[ 20357-24-8 ]

5-Methoxy-2-nitrobenzaldehyde

Similarity: 0.97

Chemical Structure| 354512-22-4

[ 354512-22-4 ]

3-Methoxy-5-nitrobenzaldehyde

Similarity: 0.95

Chemical Structure| 42454-06-8

[ 42454-06-8 ]

5-Hydroxy-2-nitrobenzaldehyde

Similarity: 0.90

Chemical Structure| 31839-20-0

[ 31839-20-0 ]

5-hydroxy-4-methoxy-2-nitrobenzoic acid

Similarity: 0.90

Chemical Structure| 53055-05-3

[ 53055-05-3 ]

3-Methoxy-2-nitrobenzaldehyde

Similarity: 0.90

Aldehydes

Chemical Structure| 20357-24-8

[ 20357-24-8 ]

5-Methoxy-2-nitrobenzaldehyde

Similarity: 0.97

Chemical Structure| 354512-22-4

[ 354512-22-4 ]

3-Methoxy-5-nitrobenzaldehyde

Similarity: 0.95

Chemical Structure| 42454-06-8

[ 42454-06-8 ]

5-Hydroxy-2-nitrobenzaldehyde

Similarity: 0.90

Chemical Structure| 53055-05-3

[ 53055-05-3 ]

3-Methoxy-2-nitrobenzaldehyde

Similarity: 0.90

Chemical Structure| 25016-02-8

[ 25016-02-8 ]

2-Methoxy-5-nitrobenzaldehyde

Similarity: 0.89

Ethers

Chemical Structure| 20357-24-8

[ 20357-24-8 ]

5-Methoxy-2-nitrobenzaldehyde

Similarity: 0.97

Chemical Structure| 354512-22-4

[ 354512-22-4 ]

3-Methoxy-5-nitrobenzaldehyde

Similarity: 0.95

Chemical Structure| 31839-20-0

[ 31839-20-0 ]

5-hydroxy-4-methoxy-2-nitrobenzoic acid

Similarity: 0.90

Chemical Structure| 53055-05-3

[ 53055-05-3 ]

3-Methoxy-2-nitrobenzaldehyde

Similarity: 0.90

Chemical Structure| 25016-02-8

[ 25016-02-8 ]

2-Methoxy-5-nitrobenzaldehyde

Similarity: 0.89

Nitroes

Chemical Structure| 20357-24-8

[ 20357-24-8 ]

5-Methoxy-2-nitrobenzaldehyde

Similarity: 0.97

Chemical Structure| 354512-22-4

[ 354512-22-4 ]

3-Methoxy-5-nitrobenzaldehyde

Similarity: 0.95

Chemical Structure| 42454-06-8

[ 42454-06-8 ]

5-Hydroxy-2-nitrobenzaldehyde

Similarity: 0.90

Chemical Structure| 31839-20-0

[ 31839-20-0 ]

5-hydroxy-4-methoxy-2-nitrobenzoic acid

Similarity: 0.90

Chemical Structure| 53055-05-3

[ 53055-05-3 ]

3-Methoxy-2-nitrobenzaldehyde

Similarity: 0.90